Dapagliflozin Effects on the Lipid Profile of Patients With Type 2 Diabetes Mellitus

被引：0
|
作者：
Hardy, Elise
Ptaszynska, Agata
De Bruin, Tjerk W. A.
Johnsson, Eva
Parikh, Shamik J.
List, James F.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1188-P
引用
收藏
页码：A310 / A310
页数：1
相关论文
共 50 条
  • [1] Effects of dapagliflozin on postprandial lipid metabolism in type 2 diabetes mellitus
    Burggraaf, Benjamin
    Pouw, Nadine M. C.
    Arroyo, Salvador Fernandez
    Van Vark-van der Zee, Leonie C.
    Van de Geijn, Gert-Jan M.
    Birnie, Erwin
    Huisbrink, Jeannine
    van der Zwan, Ellen M.
    de Herder, Wouter W.
    Mulder, Monique T.
    Rensen, Patrick C. N.
    Cabezas, Manuel Castro
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 186 (05) : 597 - 605
  • [2] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [3] Changes in lipid profiles of patients with type 2 diabetes mellitus on dapagliflozin therapy
    Hardy, E.
    Ptaszynska, A.
    de Bruin, T. W. A.
    Johnsson, E.
    Parikh, S. J.
    List, J. F.
    [J]. DIABETOLOGIA, 2013, 56 : S379 - S379
  • [4] Evaluation of the Lipid Profile in Type 2 Diabetes Mellitus Patients in Greece
    Stamouli, Marilena
    Pouliakis, Abraham
    Mourtzikou, Antonia
    Skliris, Anastasios
    Panagiotou, Ioanna
    Mournianakis, Emmanouil
    Totos, Grigorios
    [J]. CLINICAL LABORATORY, 2014, 60 (10) : 1593 - 1600
  • [5] Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
    Paul D. Rosenblit
    [J]. Cardiovascular Diabetology, 15
  • [6] Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
    Rosenblit, Paul D.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [7] Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
    Kurozumi, Akira
    Okada, Yosuke
    Arao, Tadashi
    Kobayashi, Takuya
    Masuda, Daisaku
    Yamashita, Shizuya
    Tanaka, Yoshiya
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02): : 360 - 365
  • [8] Influence of dapagliflozin on lipid parameters in patients with coronary artery disease and type 2 diabetes mellitus
    Kayumov, N.
    Alyavi, B.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
  • [9] INFLUENCE OF DAPAGLIFLOZIN ON LIPID PARAMETERS IN PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETES MELLITUS
    Ubaydullaeva, Z.
    Alyavi, A.
    Uzokov, J.
    Karimov, B.
    [J]. ATHEROSCLEROSIS, 2023, 379 : S197 - S197
  • [10] The effects of dapagliflozin on the neovascularization of carotid atherosclerosis plaques in type 2 diabetes mellitus patients
    Li, Juanjuan
    Xin, Ying
    Wang, Fang
    Dong, Xiaoyun
    Xu, Lili
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (01) : 231 - 238
12345